Amy Broidrick
Keine laufenden Positionen mehr
Profil
Amy S.
Broidrick served as Vice President & Head of Marketing at Arena Pharmaceuticals, Inc. from 2010 to 2012.
From 2013 to 2016, she worked as Vice President & Head of Global Marketing Excellence at EMD Serono, Inc. She then served as Senior Vice President of Corporate Development at Viking Therapeutics, Inc. from 2016 to 2020.
From 2020 to 2023, she was President, Director & Chief Strategy Officer at Qualigen, Inc. and then President, COO, Director & Chief Strategy Officer at Qualigen Therapeutics, Inc. in 2023.
Broidrick received her undergraduate degree from Fairleigh Dickinson University.
Ehemalige bekannte Positionen von Amy Broidrick
| Unternehmen | Position | Ende |
|---|---|---|
| QUALIGEN THERAPEUTICS, INC. | Präsident | 16.06.2023 |
Qualigen, Inc.
 Qualigen, Inc. Medical SpecialtiesHealth Technology Qualigen, Inc. operates as a biotechnology company that develops and commercializes novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a diagnostic platform. The company was founded by Michael S. Poirier in 1996 and is headquartered in Carlsbad, CA. | Präsident | 16.06.2023 |
| VIKING THERAPEUTICS, INC. | Corporate Officer/Principal | 01.07.2020 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Vertrieb & Marketing | 01.01.2016 |
| ARENA PHARMACEUTICALS | Vertrieb & Marketing | 01.01.2012 |
Ausbildung von Amy Broidrick
| Fairleigh Dickinson University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VIKING THERAPEUTICS, INC. | Health Technology |
| QUALIGEN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Qualigen, Inc. operates as a biotechnology company that develops and commercializes novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a diagnostic platform. The company was founded by Michael S. Poirier in 1996 and is headquartered in Carlsbad, CA. | Health Technology |
